carbogen has been researched along with Angiogenesis, Pathologic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Baganha, F; de Vries, MR; Parma, L; Peters, HAB; Quax, PHA; Sluimer, JC | 1 |
Baker, LC; Boult, JK; Burrell, JS; Halliday, J; Jamin, Y; Robinson, SP; Walker-Samuel, S; Waterton, JC | 1 |
Akens, MK; Cheng, HL; Winter, JD | 1 |
Baker, LC; Boult, JK; Burrell, JS; Halliday, J; Robinson, SP; Ryan, AJ; Walker-Samuel, S; Waterton, JC | 1 |
Gambarota, G; Heerschap, A; Kamm, YL; Lammens, M; Lok, J; Punt, CJ; van der Kogel, AJ; van Laarhoven, HW; Wagener, T | 1 |
Jouanneau, J; Kaffy, J; Pontikis, R; Thomas, CD; Volk, A; Walczak, C | 1 |
Chiu, RK; Koritzinsky, M; Lambin, P; Landuyt, W; Nuyts, S; Theys, J; Weppler, SA; Wouters, BG | 1 |
2 review(s) available for carbogen and Angiogenesis, Pathologic
Article | Year |
---|---|
Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI.
Topics: Animals; Carbon Dioxide; Cell Line, Tumor; Disease Models, Animal; Ferric Compounds; Heterografts; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Neovascularization, Pathologic; Oxygen; Particle Size; Prostatic Neoplasms | 2016 |
Hypoxia as a target for combined modality treatments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Cell Hypoxia; Combined Modality Therapy; Gene Expression; Humans; Neoplasms; Neovascularization, Pathologic; Niacinamide; Oxygen; Prognosis; Radiation-Sensitizing Agents | 2002 |
5 other study(ies) available for carbogen and Angiogenesis, Pathologic
Article | Year |
---|---|
Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.
Topics: Animals; Apolipoprotein E3; Apoptosis; Atherosclerosis; Blood Vessel Prosthesis; Carbon Dioxide; DNA Damage; Hemorrhage; Hypoxia; Inflammation; Macrophages; Male; Mice, Inbred C57BL; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Oxygen; Plaque, Atherosclerotic; Reactive Oxygen Species; Vascular Patency; Veins | 2020 |
Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia.
Topics: Animals; Carbon Dioxide; Hypercapnia; Hyperoxia; Magnetic Resonance Imaging; Microspheres; Neovascularization, Pathologic; Oxygen; Rabbits; Soft Tissue Neoplasms; Tumor Burden | 2011 |
Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging.
Topics: Animals; Carbon Dioxide; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Female; Ferric Compounds; Fluorescence; Humans; Magnetic Resonance Imaging; Magnetics; Mice; Mice, Nude; Neovascularization, Pathologic; Oxygen; Radiation-Sensitizing Agents; Time Factors | 2011 |
Carbogen breathing differentially enhances blood plasma volume and 5-fluorouracil uptake in two murine colon tumor models with a distinct vascular structure.
Topics: Animals; Antimetabolites, Antineoplastic; Carbon Dioxide; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Fluorine Radioisotopes; Fluorouracil; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neovascularization, Pathologic; Oxygen; Phosphorus Radioisotopes; Plasma; Radiation-Sensitizing Agents; Respiration | 2006 |
Early effects of combretastatin A4 phosphate assessed by anatomic and carbogen-based functional magnetic resonance imaging on rat bladder tumors implanted in nude mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Dioxide; Contrast Media; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Oxygen; Radiation-Sensitizing Agents; Rats; Stilbenes; Time Factors; Urinary Bladder Neoplasms | 2006 |